Evidence map›Paper›PMID 35147810›Full record

ArticleEJNMMI research2022

Comparison of

Chuanchi Zhou, Yongxiang Tang, Zhihe Deng, Jinhui Yang, Ming Zhou, Long Wang, Shuo Hu

Abstract read
In one paragraph

Article in EJNMMI research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Comparison ofFrontiers in oncology · 2024
    Pooled it
  3. A prospective head-to-head comparison of [European journal of nuclear medicine and molecular imaging · 2023
    Trial
  4. Article
  5. Review
  6. Detection Accuracy of [World journal of nuclear medicine · 2025
    Article
  7. Article
  8. Clinical value of [Theranostics · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. [Frontiers in endocrinology · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Comparison of PSMA-basedAmerican journal of nuclear medicine and molecular imaging · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Chuanchi Zhou *Department of Urology, The Third Xiangya Hospital, Central South University, 138 Tongzipo Road, Changsha, 410013, Hunan, China.
Yongxiang Tang *Department of Nuclear Medicine, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha, 410008, Hunan, China.ORCID http://orcid.org/0000-0003-3987-8702
Zhihe Deng *Department of Vascular Surgery, The Second Affiliated Hospital of University of South China, Hengyang, China.
Jinhui YangDepartment of Nuclear Medicine, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha, 410008, Hunan, China.
Ming ZhouDepartment of Nuclear Medicine, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha, 410008, Hunan, China.
Long WangDepartment of Urology, The Third Xiangya Hospital, Central South University, 138 Tongzipo Road, Changsha, 410013, Hunan, China. wanglong@csu.edu.cn.
Shuo HuDepartment of Nuclear Medicine, Xiangya Hospital, Central South University, 87 Xiangya Road, Changsha, 410008, Hunan, China. hushuo2018@163.com.ORCID http://orcid.org/0000-0003-0998-8943

Funding

National Natural Science Foundation of China 81770758National Natural Science Foundation of China 81771873National Natural Science Foundation of China 91859207
6 · The paper itself

Abstract

purposeTo assess

methodsWe conducted a retrospective analysis of patients who had undergone a prostate biopsy and/or radical prostatectomy and who were scanned with

resultA total of 101 patients who were pathologically diagnosed with PCa were analyzed. Of the 101 patients, 88 (80.6%) patients presented with a pathologic mpMRI, and 85 (79.1%) with a pathologic

conclusionThe diagnostic performance of

Indexed as

MRIPET/CTProstate cancerProstate-specific membrane antigenPSMA

Identifiers

PMID35147810
PMCPMC8837766

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.